General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Winthrop KL et al. – The findings highlight that these cases are occurring in such patients, often with devastating outcomes. Future population–based studies are necessary to determine risks for such complications and to define preventive and therapeutic strategies for such patients. For now, clinicians should remain vigilant for these and other types of serious infections that occur in patients using these compounds.

Related Articles

Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis
Respiratory Medicine, 11/13/09    Relevance Score: 64%

Antituberculous vaccine development: a perspective for the endemic world
Expert Review of Vaccines, 11/04/09    Relevance Score: 64%

Non-tuberculous mycobacteria in children with cystic fibrosis: Isolation, prevalence, and predictors
Pediatric Pulmonology, 10/21/09    Relevance Score: 64%

Nontuberculous Mycobacteria-associated Lung Disease, United States in Hospitalized Persons, 1998-2005
Emerging Infectious Diseases, 10/15/09    Relevance Score: 64%

Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09    Relevance Score: 63%

Today in Other Viral/Bacterial...keeping you current

Postexposure Rabies Prophylaxis Completed in 1 Week: Preliminary Study
Clinical Infectious Diseases, 12/15/09

Opportunities for Emergency Medical Services care of sepsis
Resuscitation, 12/15/09

Hospital-Acquired Staphylococcus aureus Infections at Texas Children's Hospital, 2001-2007
Infection Control and Hospital Epidemiology, 12/15/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address